Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03233399 · ClinicalTrials.gov registry record · NA
Modulating Movement Intention Via Cortical Stimulation
A NA study of Seizures and Seizure Disorder, sponsored by NYU Langone Health.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT03233399: Recruiting NA study of Seizures and Seizure Disorder, sponsored by NYU Langone Health.
NCT03233399 is a NA study of Seizures and Seizure Disorder that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 30 participants, below the 934-participant average among 39 other Seizures trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03233399, a NA study of Seizures and Seizure Disorder, is actively recruiting participants, sponsored by NYU Langone Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this protocol is to learn about movement intention and volition. To improve such knowledge, investigators will conduct sub-studies using multiple non-invasive methodologies. These results could provide preliminary data for subsequent studies evaluating local and global efficacy of plasticity-inducing treatments for PMD symptoms.
Primary Outcome
as a result of altering cerebral perfusion in response to neurophysiologic stimulation
Conditions Studied
Interventions
- DEVICE Sham TMS3 stimulation
- DEVICE rTMS of left or right angular gyrus (AG) or frontal cortex (FC)
- DEVICE Anodal tDCS of left or right AG or FC
Study Locations (1)
New York
- New York University School of Medicine - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2017-07-20 |
| Est. Completion | 2027-05 |
| Phase | NA |
What NCT03233399 shows while recruiting
NCT03233399 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 934-participant average among 39 other Seizures trials with a reported enrollment target (97% lower).
The record links to 3 conditions, with Seizures appearing as the primary indexed condition, and to 3 interventions - of which Sham TMS3 stimulation is the first listed.
NCT03233399 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03233399 about?
NCT03233399 is a clinical study titled "Modulating Movement Intention Via Cortical Stimulation". The purpose of this protocol is to learn about movement intention and volition. To improve such knowledge, investigators will conduct sub-studies using multiple non-invasive methodologies. These results could provide preliminary data for subsequent studies evaluating local and global efficacy of pla...
What is the current status of trial NCT03233399?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2017-07-20. Estimated completion is 2027-05.
What conditions does trial NCT03233399 study?
This clinical trial studies the following conditions: Seizures, Seizure Disorder, Psychogenic Movement Disorder.
What interventions are being tested in trial NCT03233399?
The interventions under investigation include: Sham TMS3 stimulation (DEVICE), rTMS of left or right angular gyrus (AG) or frontal cortex (FC) (DEVICE), Anodal tDCS of left or right AG or FC (DEVICE).
Who is sponsoring clinical trial NCT03233399?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03233399 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Seizures
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03233399's enrollment target sits among peer trials
30 32nd of 39 higher than 7 of 39 other Seizures trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Seizures trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Glioblastoma Remote Monitoring and Care - Research Protocol
RECRUITING · NA
-
Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy
RECRUITING · NA
-
Oxygen Toxicity: Mechanisms in Humans
RECRUITING · NA
-
Ear-Seizure Detection (EarSD) Study
RECRUITING · NA
-
Impact of Capturing Ictal Events With Ultra-long-term Ambulatory EEG Monitoring With Remote EEG Monitoring System.
RECRUITING · NA
-
Acute Effects of Focused Ultrasound Modulation on EEG Behavior in Status Epilepticus Patients
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI